Latest filing published 28 Jul 2015 for Neos Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ralph Iannelli: trading record in brief
Ralph Iannelli discloses dealings in Neos Therapeutics, Inc. to SEC (Form 4). In total, 12 filings cover trades dated 28 July 2015.
The open-market record is one-sided, with 1 purchase worth €407k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 28 July 2015: a transaction, in Neos Therapeutics, Inc. The clock since the last published purchase (28 July 2015) now reads 4,122 days. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ralph Iannelli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,332 sharesCommon StockSEC:0001104659-15-053969:8
- 2,958 sharesCommon StockSEC:0001104659-15-053969:9
- 1,666 sharesCommon StockSEC:0001104659-15-053969:10
- 237,500 sharesCommon StockSEC:0001104659-15-053969:3
- 20,833 sharesCommon StockSEC:0001104659-15-053969:4
- 8,333 sharesCommon StockSEC:0001104659-15-053969:5
- 56,874 sharesCommon StockSEC:0001104659-15-053969:6
- 81,249 sharesCommon StockSEC:0001104659-15-053969:7
- 386,415 sharesCommon StockSEC:0001104659-15-053969:0
- 31,437 sharesCommon StockSEC:0001104659-15-053969:1
- 83,333 sharesCommon StockSEC:0001104659-15-053969:2
- 30,000 shares@ US$15.00Common StockSEC:0001104659-15-053969:11Canonical exit: 26 Oct 2015 (T+90)
12 of 12 declarations
